Skip to main content

Advertisement

Log in

Outcome of a Novel Drug Combination in the Medical Management of Oral Submucous Fibrosis Patients: A Retrospective Cohort Study

  • ORIGINAL ARTICLE
  • Published:
Journal of Maxillofacial and Oral Surgery Aims and scope Submit manuscript

Abstract

Aim

To evaluate the efficacy of a new drug combination in the medical management of oral submucous fibrosis (OSMF) patients.

Materials and Methods

This retrospective cohort study included 89 patients who were clinically diagnosed of having OSMF (grade I, II, III). These patients had been administered the new drug combination for 6 months and clinical parameters such as burning sensation score, mouth opening and tongue protrusion were evaluated at 1 month, 3 months, 6 months and 12 months post-medication retrospectively.

Results

Out of the total 89 patients included in the study, 18 patients had Grade-I, 50 patients had Grade-II and 21 patients had Grade-III OSMF. A significant improvement was observed in the mouth opening and tongue protrusion in all the three grades of OSMF from baseline to 1 month, 3 months, 6 months and 12 months after treatment (p < 0.0001) on intra- and intergroup comparison. A significant reduction in the burning sensation score from baseline to 1 month, 3 months, 6 months and 12 months after treatment was observed (p < 0.0001) in all the three grades on intra group comparison.

Conclusion

This retrospective study showed that this novel drug combination is significantly effective in improving burning sensation score, mouth opening and tongue protrusion in OSMF grade I, II and III patients with results consistent after 1 year of follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Pindborg JJ, Sirsat SM (1966) Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 22:765–779. https://doi.org/10.1016/0030-4220(66)90367-7

    Article  Google Scholar 

  2. Mahato B, Prodhan C, Mandal S, Dutta A, Kumar P, Deb T, Jha T, Chaudhuri K (2019) Evaluation of efficacy of curcumin along with lycopene and piperine in the management of oral submucous fibrosis. Contemp Clin Dent 10(3):531–541. https://doi.org/10.4103/ccd.ccd_937_18

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. More CB, Jatti Patil D, Rao NR (2020) Medicinal management of oral submucous fibrosis in the past decade—a systematic review. J Oral Biol Craniofac Res 10(4):552–568. https://doi.org/10.1016/j.jobcr.2020.08.004

    Article  PubMed  PubMed Central  Google Scholar 

  4. Rajalalitha P, Vali S (2005l) Molecular pathogenesis of oral submucous fibrosis—a collagen metabolic disorder. J Oral Pathol Med 34(6):321–328. https://doi.org/10.1111/j.1600-0714.2005.00325.x

    Article  CAS  PubMed  Google Scholar 

  5. More CB, Gupta S, Joshi J, Verma SN (2012) Classification System For Oral Submucous Fibrosis. J Indian Acad Oral Med Radiol 24:24–29. https://doi.org/10.5005/jp-journals-10011-1254

    Article  Google Scholar 

  6. Kania J, Dhuvad J, Anchlia S et al (2022) Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. J Maxillofac Oral Surg. https://doi.org/10.1007/s12663-022-01741-2

    Article  Google Scholar 

  7. Singh N, Hebbale M, Mhapuskar A, Ul Nisa S, Thopte S, Singh S (2016) Effectiveness of aloe vera and antioxidant along with physiotherapy in the management of oral submucous fibrosis. J Contemp Dent Pract 17(1):78–84. https://doi.org/10.5005/jp-journals-10024-1806

    Article  PubMed  Google Scholar 

  8. Anonymous IARC (1985) Betel-quid and areca-nut chewing; and some related nitrosamines, volume 85. IARC Monograph Eval Carcinog Risk Chem Hum 37:141–200

    Google Scholar 

  9. Bhandarkar GP, Shetty KV, Kulkarni A (2018) Thioctic acid in oral submucous fibrosis (India’s disease)—a better tomorrow. J Stomatol Oral Maxillofac Surg 119(2):129–134. https://doi.org/10.1016/j.jormas.2017.12.006

    Article  CAS  PubMed  Google Scholar 

  10. Khan S, Chatra L, Prashanth SK, Veena KM, Rao PK (2012) Pathogenesis of oral submucous fibrosis. J Cancer Res Ther 8(2):199–203. https://doi.org/10.4103/0973-1482.98970

    Article  PubMed  Google Scholar 

  11. Maher R, Aga P, Johnson NW, Sankaranarayanan R, Warnakulasuriya S (1997) Evaluation of multiple micronutrient supplementation in the management of oral submucous fibrosis in Karachi, Pakistan. Nutr Cancer 27(1):41–47. https://doi.org/10.1080/01635589709514499

    Article  CAS  PubMed  Google Scholar 

  12. Borle RM, Borle SR (1991) Management of oral submucous fibrosis: a conservative approach. J Oral Maxillofac Surg 49(8):788–791. https://doi.org/10.1016/0278-2391(91)90002-4

    Article  CAS  PubMed  Google Scholar 

  13. Ahmad T, Khan I, Rizvi MM, Saalim M, Manzoor N, Sultana A (2021) An overview of effect of lycopene and curcumin in oral leukoplakia and oral submucous fibrosis. Natl J Maxillofac Surg 12(3):316–323. https://doi.org/10.4103/njms.njms_324_21

    Article  PubMed  PubMed Central  Google Scholar 

  14. Gupta N, Kalaskar A, Kalaskar R (2020) Efficacy of lycopene in management of oral submucous fibrosis—a systematic review and meta-analysis. J Oral Biol Craniofac Res 10(4):690–697. https://doi.org/10.1016/j.jobcr.2020.09.004

    Article  PubMed  PubMed Central  Google Scholar 

  15. Rao PK (2010) Efficacy of alpha lipoic acid in adjunct with intralesional steroids and hyaluronidase in the management of oral submucous fibrosis. J Cancer Res Ther 6(4):508–510. https://doi.org/10.4103/0973-1482.77087

    Article  CAS  PubMed  Google Scholar 

  16. More CB, Gavli N, Chen Y, Rao NR (2018) A novel clinical protocol for therapeutic intervention in oral submucous fibrosis: an evidence based approach. J Oral Maxillofac Pathol 22(3):382–391. https://doi.org/10.4103/jomfp.JOMFP_223_18

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

No funding was received for conducting this study by any organization.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Samruddhi J. Borate.

Ethics declarations

Conflict of interests

CAPSULE SMF CARE® is a registered trademark of author 1 and the author holds proprietary interest with the same.

Ethical approval

Ethical approval was waived by the local Ethics Committee of “Institutional Ethics Committee Human, Gokul Lifecare Private Limited” in view of the retrospective nature of the study, and all the procedures being performed were part of the routine care.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pethani, K.H., Borate, S.J. Outcome of a Novel Drug Combination in the Medical Management of Oral Submucous Fibrosis Patients: A Retrospective Cohort Study. J. Maxillofac. Oral Surg. (2024). https://doi.org/10.1007/s12663-023-02096-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12663-023-02096-y

Keywords

Navigation